Paclitaxel Impurity 95 | CAS 157826-10-3 - Request Quote
Paclitaxel Impurity 95
| SZ CAT No: | SZ-P032197 |
| CAS No | 157826-10-3 |
| Mol.F. | C24H21NO5 |
| Mol.Wt. |
403.4 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Paclitaxel Impurity 95 is chemically (2R,4S,5R)-3-benzoyl-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid. Paclitaxel Impurity 95 is supplied with detailed characterization data compliant with regulatory guideline. Paclitaxel Impurity 95 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Paclitaxel.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 157826-10-3
Purchase 157826-10-3
Order 157826-10-3
Enquire 157826-10-3
price of 157826-10-3
157826-10-3 Supplier
157826-10-3 Manufacturer
157826-10-3 Exporter
buy high quality Paclitaxel Impurity 95
Purchase Paclitaxel Impurity 95
Paclitaxel Impurity 95 suppliers
Paclitaxel Impurity 95 manufacturers
Paclitaxel Impurity 95 price
Order Paclitaxel Impurity 95
Enquire Paclitaxel Impurity 95
Paclitaxel Impurity 95 cost
Paclitaxel Impurity 95 Supplier
Paclitaxel Impurity 95 Distributor
Paclitaxel Impurity 95 for Method Validation
Paclitaxel Reference Standard
Paclitaxel Impurity 95 for ANDA Filing
Paclitaxel Impurity 95 for Forced Degradation Studies
Paclitaxel Impurity 95 Identification Standards
Paclitaxel Impurity 95 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.